Resource data sheet
Prev.
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pENTER-EGFR wild-type

Gateway(R) entry vector of human epidermal growth factor receptor (EGFR), wild type.

Catalog number RDB15488
Resource name pENTER-EGFR wild-type
Clone info. Gateway(R) entry vector of human epidermal growth factor receptor (EGFR), wild type.
Comment cDNA was obtained from A549 cells. Expression was confirmed by the depositor with western blotting after cloned into pLenti6.3 vector (by LR clonase II reaction).
Vector backbone pENTR (plasmid)
Size of vector backbone 2.6 kb
Selectable markers Kan^r
Gene/insert name human EGFR cDNA
Depositor|Developer Katayama, Ryohei |
Other clones in our bank

External Database
human EGFR

          Reference sequence
            

          Distribution information

          Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
          Terms and conditions set forth by the DEPOSITOR In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature designated by the DEPOSITOR is requested. (Uchibori, K et al. Nat. Commun. 8: 14768, 2017)
          Ordering Please visit Information of Request for Distribution.[link] 
          Order form 
          [Credit Card Payment]  [Bank Transfer Payment]
          Material Transfer Agreement (MTA for use for not-for-profit academic purpose) [Word]
          Remarks
          Gateway® Entry clone. Please refer Life Technologies Corporation signs license agreement with RIKEN BRC.
          提供案内 (日本国内) [open/close]

          提供条件 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(Uchibori, K et al. Nat. Commun. 8: 14768, 2017)。
          提供依頼 手続きの詳細は、「提供申込みについて[link]」をご覧ください。
          提供依頼書 [Word]
          提供同意書 (MTA、非営利機関による非営利学術研究用)[Word]
          備考
          Gateway®テクノロジーを用いたエントリークローンです。「Gateway®テクノロジーを用いたクローンの提供と寄託のご案内」をご覧ください。

          Catalog # Resource name Shipping form Fee (non-profit org.)
          RDB15488 pENTER-EGFR wild-type DNA solution

          Please review the QC test results indicated by check icon below as well as clone information before placing your order.

          References and tips

          Electronic file

          Original reference

          original Uchibori, K., Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer. Nat. Commun. 8: 14768 (2017). PMID 28287083.

          Further references such as user reports and related articles (go to bottom)

          Featured content


          Sequence information

          RIKEN BRC has sequenced portions of this material for quality test.
          Please review the QC test results indicated by check icon as well as clone information before placing your order.

          Test sheet RDB15488_A7K8p1-1.pdf check

          Nucleotide sequence of a portion of this resource (if available).

          Primer: rrnBT1ter_F2
          Region: rrnB T1 ter, attL1, insert 5'
          Sequence file: RDB15488_A7K8a.seq check
          >D04925A1_A7K8_2_rrnBT1ter_F2_A04_01_ABI24.ab1
              1 AGTCAGATCT TCGACTGAGC CTTTCGTTTT ATTTGATGCC TGGCAGTTCC CTACTCTCGC
             61 GTTAACGCTA GCATGGATGT TTTCCCAGTC ACGACGTTGT AAAACGACGG CCAGTCTTAA
            121 GCTCGGGCCC CAAATAATGA TTTTATTTTG ACTGATAGTG ACCTGTTCGT TGCAACAAAT
            181 TGATGAGCAA TGCTTTTTTA TAATGCCAAC TTTGTACAAA AAAGCAGGCT CCGCGGCCGC
            241 CCCCTTCACC ATGCGACCCT CCGGGACGGC CGGGGCAGCG CTCCTGGCGC TGCTGGCTGC
            301 GCTCTGCCCG GCGAGTCGGG CTCTGGAGGA AAAGAAAGTT TGCCAAGGCA CGAGTAACAA
            361 GCTCACGCAG TTGGGCACTT TTGAAGATCA TTTTCTCAGC CTCCAGAGGA TGTTCAATAA
            421 CTGTGAGGTG GTCCTTGGGA ATTTGGAAAT TACCTATGTG CAGAGGAATT ATGATCTTTC
            481 CTTCTTAAAG ACCATCCAGG AGGTGGCTGG TTATGTCCTC ATTGCCCTCA ACACAGTGGA
            541 GCGAATTCCT TTGGAAAACC TGCAGATCAT CAGAGGAAAT ATGTACTACG AAAATTCCTA
            601 TGCCTTAGCA GTCTTATCTA ACTATGATGC AAATAAAACC GGACTGAAGG AGCTGCCCAT
            661 GAGAAATTTA CAGGAAATCC TGCATGGCGC CGTGCGGTTC AGCAACAACC CTGCCCTGTG
            721 CAATGTGGAG AGCATCCAGT GGCGGGACAT AGTCAGCAGT GACTTTCTCA GCAACATGTC
            781 GATGGACTTC CAGAACCACC TGGGCAGCTG CCAAAAGTGT GATCCAAGCT GTCCCAATGG
            841 GAGCTGCTGG GGTGCAGGAG AGGAGAACTG CCAGAAACTG ACCAAAATCA TCTGTGCCCA
            901 GCAGTGCTCC GGGCGCTGCC GTGGCAAGTC CCCCCAGTGA CTGCTGCCAC AACCAGTGTG
            961 CTGCAGGCTG CACAGGCCCC CCGGGAGAGC GACTGCCCTG GGTCTGCCGC AAATTCCCGA
           1021 GACGAAAGCC ACGTGCAAGG ACACCTGCCC CCCCCACTCA TGCTCTACAA CCCCCACCAC
          1081 GTACCAGATG TATGTGAAAC CCCGAGGGGC AAAATAACAA GCCTTTTTGG AATGC
          //
          Primer: pDONR_R
          Region: attL2, insert 3'
          Sequence file: RDB15488_A7K8b.seq check
          >D04925A1_A7K8_2_pDONR_R_A08_02_ABI24.ab1
              1 GGCGGACGTC AGGGACGCTA TGACCATGTA ATACGACTCA CTATAGGGGA TATCAGCTGG
             61 ATGGCAAATA ATGATTTTAT TTTGACTGAT AGTGACCTGT TCGTTGCAAC AAATTGATAA
            121 GCAATGCTTT CTTATAATGC CAACTTTGTA CAAGAAAGCT GGGTCGGCGC GCCCACCCTT
            181 TCATGCTCCA ATAAATTCAC TGCTTTGTGG CGCGACCCTT AGGTATTCTG CATTTTCAGC
            241 TGTGGAGCCC TTAAAGATGC CATTTGGCTT GGCTTCCTTG GGAAAGAAGT CCTGCTGGTA
            301 GTCAGGGTTG TCCAGGCTAA TTTGGTGGCT GCCTTTCTGG GCCCAGTGGG CAGGGCTGTC
            361 GAATGTGCTG TTGACACAGG TGGGCTGGAC AGTGTTGAGA TACTCGGGGT TGCCCACTGC
            421 AGTGCTGTGG GGGTCCTGGT AGTGTGGGTC TCTGCTGGGC GCGGGGTTCA GAGGCTGATT
            481 GTGATAGACA GGATTCTGCA CAGAGCCAGC GGGCCTTTTG GGAACGGACT GGTTTATGTA
            541 TTCAGGCACT GGGAGGAAGG TGTCGTCTAT GCTGTCCTCA GTCAAGGCGC CTGTGGGGTC
            601 TGAGCTGTAT CGCTGCAAGA AGCTGTCTTC CTTGATGGGA CAGCTTTGCA GCCCATTTCT
            661 ATCAATGCAA GCCACGGTGG AATTGTTGCT GGTTGCACTC AGAGAGCTCA GGAGGGGAGT
            721 CCGTGACGTG GAGGGGCTGC TGAAGAAGCC CTGCTGTGGG ATGAGGTACT CGTCGGCATC
            781 CACCACGTCG TCCATGTCTT CTTCATCCAT CAGGGCACGG TAGAAGTTGG AGTCTGTAGG
            841 ACTTGGCAAA TGCATTCTTT CATCCCCCCT GAATGACAAG GTAGCGCTGG GGGGTCTCGG
            901 GGCCATTTTG GAGAATTCGA TGATCAACTC ACGGGAACTT TGGGGCGACT ATCTGCGTCT
            961 ATCATCCAGC ACTTGACCAT GATCATGTAG ACATCGATGG TACATATGGG TGGCTGAGGG
           1021 AGGCGTTTCT CCCTTTTCTC CAGGATGGAG GAGATCTCGC TGGCAGGATC GGTCATATGG
          1081 CCTTGGCATC CAAGGATCAA TCAACTTCTC A
          //
          Primer: EGFR-F5
          Region: insert middle region
          Sequence file: RDB15488_A7K8c.seq check
          >D04925A1_A7K8_2_EGFR-F5_A09_03_ABI24.ab1
              1 AACAATAATC GTCCATCGCC ACTGGGATGG TGGGGGCCCT CCTCTTGCTG CTGGTGGTGG
             61 CCCTGGGGAT CGGCCTCTTC ATGCGAAGGC GCCACATCGT TCGGAAGCGC ACGCTGCGGA
            121 GGCTGCTGCA GGAGAGGGAG CTTGTGGAGC CTCTTACACC CAGTGGAGAA GCTCCCAACC
            181 AAGCTCTCTT GAGGATCTTG AAGGAAACTG AATTCAAAAA GATCAAAGTG CTGGGCTCCG
            241 GTGCGTTCGG CACGGTGTAT AAGGGACTCT GGATCCCAGA AGGTGAGAAA GTTAAAATTC
            301 CCGTCGCTAT CAAGGAATTA AGAGAAGCAA CATCTCCGAA AGCCAACAAG GAAATCCTCG
            361 ATGAAGCCTA CGTGATGGCC AGCGTGGACA ACCCCCACGT GTGCCGCCTG CTGGGCATCT
            421 GCCTCACCTC CACCGTGCAA CTCATCACGC AGCTCATGCC CTTCGGCTGC CTCCTGGACT
            481 ATGTCCGGGA ACACAAAGAC AATATTGGCT CCCAGTACCT GCTCAACTGG TGTGTGCAGA
            541 TCGCAAAGGG CATGAACTAC TTGGAGGACC GTCGCTTGGT GCACCGCGAC CTGGCAGCCA
            601 GGAACGTACT GGTGAAAACA CCGCAGCATG TCAAGATCAC AGATTTTGGG CTGGCCAAAC
            661 TGCTGGGTGC GGAAGAGAAA GAATACCATG CAGAAGGAGG CAAAGTGCCT ATCAAGTGGA
            721 TGGCATTGGA ATCAATTTTA CACAGAATCT ATACCCACCA GAGTGATGTC TGGAGCTACG
            781 GGGTGACCGT TTGGGAGTTG ATGACCTTTG GATCCAAGCC ATATGACGGA ATCCCTGCCA
            841 GCGAGATCTC CTCCATCCTG GAGAAAGGAG AACGCCTCCC TCAGCCACCC ATATGTACCA
            901 TCGATGTCTA CATGATCATG GTCAAGTGCT GGATGATAGA CGCAGATAGT CGCCCAAAGT
            961 TCCGTGAGTT GATCATCGAA ATTCTCCAAA ATGGGCCGAG ACCCCCAGCG CTACCCTTGT
           1021 CATTCAGGGG GATGAAAGAA TGCATTTGCC CAGTCCTACA GACTCCAACT CTAACGTGTC
          1081 TGGATTGATG AAGAGGACAT TGGCACGAAA CCGT
          //

          Please visit Sequencing and PCR primers for primer information.


          References

          Original, user report and related articles

          original Uchibori, K., Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer. Nat. Commun. 8: 14768 (2017). PMID 28287083.

          2022.05.17

          GNP_filter3_RDBDEP_html_220516.pl